Otherwise, concentrations have to be evaluated with consideration of position. 2 Lower levels are to be expected in bedridden patients.
Lastly, Bruguerolle et al. 7 suggested that circadian rhythm was defined for serum prealbumin. We think that it is essential to define sampling time for the measurement of serum prealbumin to present reliable data. Therefore, interpretation of findings with its current form seems problematic.
In conclusion, we believe that the study of Bicakli et al. 1 contributes valuable data to medical literature. However, clarifying these concerns will provide clearer picture to the readers.
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